Stockreport

Viatris- Theramex deal for women's care products raises antitrust concerns in U.K. Apr. 04, 2024 8:55 AM ET By: Dulan Lokuwithana , SA News Editor [Seeking Alpha]

Viatris Inc.  (VTRS) 
PDF divest the European rights to its women's healthcare products, Duphaston and Femoston, to Theramex. Duphaston and Femoston, which comprise progesterone and estrogen re [Read more]